Phase 2 Trial of RGX-314 in Adults With Center Involved - Diabetic Macular Edema (CI - DME)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2025
Phase 2 open label, randomized, active controlled, dose-ranging trial in adults with Center Involved - Diabetic Macular Edema (CI - DME)
Epistemonikos ID: dd31f570cf0f343ae7bbdcb15b5cc16351599f60
First added on: Apr 25, 2025